Haaglanden Medisch Centrum Stichting

Neurovascular Care

Research activity is centered on aneurysmal subarachnoid hemorrhage, with clinical interest in the acute complications that follow rupture and the neurological consequences of subarachnoid hemorrhage.

  • Subarachnoid hemorrhage
  • Aneurysmal bleeding
  • Neurological injury

The trial portfolio reflects a focus on cerebrovascular disease and the management of patients at risk of secondary brain injury after hemorrhagic events.

Inflammation and Complement System

Clinical interest includes modulation of the complement system and its role in post-hemorrhagic inflammatory response, particularly in relation to delayed neurological deterioration.

  • Complement inhibition
  • Inflammatory response
  • Immune-mediated brain injury

The research setting includes evaluation of therapies aimed at reducing complement-driven tissue damage in acute neuroinflammation.

Cerebral Ischemia and Outcome Preservation

Another key area is the prevention of delayed cerebral ischemia following hemorrhage, with attention to preserving neurological function and improving recovery after acute vascular brain injury.

  • Delayed cerebral ischemia
  • Neurological outcome
  • Brain perfusion

Clinical research is directed toward mechanisms that may limit secondary ischemic damage in patients with SAH.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of C1 Esterase Inhibitor and Sodium Chloride for Patients with Aneurysmal Subarachnoid Hemorrhage

    Not yet recruiting

    1 1
    Investigated diseases:
    The Netherlands